Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00307_DB00560_nanopub.RAU_dILSUs6w441FKFLdEajeCLzr4PCxu6-xx5j02LDdU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00307_DB00560 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00307_DB00560 label "DDI between Bexarotene and Tigecycline - Tigecycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. The development of pseudotumor cerebri (intracranial hypertension) is of particular concern. Avoid this combination. [drugbank_resource:DB00307_DB00560]" assertion.
- drugbank_resource:DB00307_DB00560 identifier "drugbank_resource:DB00307_DB00560" assertion.
- drugbank_resource:DB00307_DB00560 title "DDI between Bexarotene and Tigecycline - Tigecycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. The development of pseudotumor cerebri (intracranial hypertension) is of particular concern. Avoid this combination." assertion.
- drugbank:DB00307 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00307_DB00560 assertion.
- drugbank:DB00560 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00307_DB00560 assertion.